AR034372A1 - Composiciones farmaceuticas - Google Patents
Composiciones farmaceuticasInfo
- Publication number
- AR034372A1 AR034372A1 ARP020102107A ARP020102107A AR034372A1 AR 034372 A1 AR034372 A1 AR 034372A1 AR P020102107 A ARP020102107 A AR P020102107A AR P020102107 A ARP020102107 A AR P020102107A AR 034372 A1 AR034372 A1 AR 034372A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical compositions
- chitosan
- once
- ketotifen
- eye
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920001661 Chitosan Polymers 0.000 abstract 2
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 abstract 2
- 229960004958 ketotifen Drugs 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000003732 agents acting on the eye Substances 0.000 abstract 1
- 206010015907 eye allergy Diseases 0.000 abstract 1
- 229940023490 ophthalmic product Drugs 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Se da a conocer una composición de fármaco oftálmico de una vez al día, en particular cetotifeno, que comprende un polímero que comprende quitosano y un vehículo, y un método para tratar una alergia ocular, el cual comprende administrar una composición oftálmica de cetotifeno de una vez al día que comprende quitosano, al ojo de un mamífero.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29706801P | 2001-06-08 | 2001-06-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR034372A1 true AR034372A1 (es) | 2004-02-18 |
Family
ID=23144721
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020102107A AR034372A1 (es) | 2001-06-08 | 2002-06-06 | Composiciones farmaceuticas |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20030031718A1 (es) |
| AR (1) | AR034372A1 (es) |
| PE (1) | PE20030064A1 (es) |
| WO (1) | WO2002100376A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002345015A1 (en) * | 2001-06-08 | 2002-12-23 | Novartis Pharma Gmbh | Ophthalmic once-a-day composition |
| PL1637141T3 (pl) * | 2004-09-21 | 2012-04-30 | Trobio Ab | Stabilizowana kompozycja proteazy zawierająca proteazę serynową, pochodne morfoliny i odwracalne inhibitory tej proteazy serynowej |
| US20070208058A1 (en) * | 2004-10-25 | 2007-09-06 | Bryant Roy W | Stable Pharmaceutical Compositions and Methods of Making and Using Same |
| US20060089384A1 (en) * | 2004-10-25 | 2006-04-27 | Minno George E | Ophthalmic compositions and methods of using the same |
| CN101087607B (zh) * | 2004-10-25 | 2010-07-28 | 博士伦公司 | 眼用组合物及使用其的方法 |
| US20070048389A1 (en) * | 2005-08-26 | 2007-03-01 | Fu-Pao Tsao | Stabilized and preserved ketotifen ophthalmic compositions |
| US20070048388A1 (en) * | 2005-08-26 | 2007-03-01 | Fu-Pao Tsao | Stabilized and preserved ketotifen ophthalmic compositions |
| US20070077303A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for providing oxidatively stable ophthalmic compositions |
| US20070077302A1 (en) * | 2005-09-30 | 2007-04-05 | Azaam Alli | Methods for stabilizing ophthalmic compositions |
| US20090092574A1 (en) * | 2006-12-29 | 2009-04-09 | Scott Richard W | Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof |
| US20090005362A1 (en) * | 2007-06-26 | 2009-01-01 | Vo Toan P | Compositions Comprising Antihistamines or Mast Cell Stabilizers, and Methods of Making and Using Same |
| TWI520951B (zh) | 2011-05-16 | 2016-02-11 | 塞爾西優蒂克斯公司 | 用於治療粘膜炎的化合物 |
| WO2014150899A1 (en) * | 2013-03-15 | 2014-09-25 | Chapin Matthew J | Topical ophthalmic formulations for treating migraine |
| US11771694B2 (en) | 2020-06-05 | 2023-10-03 | Innovation Pharmaceuticals Inc. | Arylamide compounds for treatment and prevention of viral infections |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5422116A (en) * | 1994-02-18 | 1995-06-06 | Ciba-Geigy Corporation | Liquid ophthalmic sustained release delivery system |
| TW389694B (en) * | 1995-08-17 | 2000-05-11 | Novartis Ag | Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics |
| EP0938896A1 (en) * | 1998-01-15 | 1999-09-01 | Novartis AG | Autoclavable pharmaceutical compositions containing a chelating agent |
| US6777429B1 (en) * | 1999-07-23 | 2004-08-17 | Novartis Ag | Ophthalmic composition |
-
2002
- 2002-06-06 AR ARP020102107A patent/AR034372A1/es unknown
- 2002-06-07 WO PCT/EP2002/006280 patent/WO2002100376A1/en not_active Ceased
- 2002-06-07 PE PE2002000486A patent/PE20030064A1/es not_active Application Discontinuation
- 2002-06-07 US US10/164,756 patent/US20030031718A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002100376A1 (en) | 2002-12-19 |
| PE20030064A1 (es) | 2003-03-18 |
| US20030031718A1 (en) | 2003-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR034372A1 (es) | Composiciones farmaceuticas | |
| AR034371A1 (es) | Composiciones farmaceuticas | |
| CA2440764A1 (en) | Combination of brimonidine and timolol for topical ophthalmic use | |
| BRPI0506983A (pt) | composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico | |
| WO2008011836A3 (es) | Soluciones oftálmicas | |
| EA200870396A1 (ru) | Лечение аллергических заболеваний глаз | |
| EA200970623A1 (ru) | Гель, применимый для доставки офтальмологических лекарственных средств | |
| WO2004052228A3 (en) | Pharmacological vitreolysis | |
| ECSP056159A (es) | Composición de fármaco conjugado | |
| BRPI0513424A (pt) | tratamento de pele com luz e agente de benefìcio | |
| DE60225701D1 (de) | Ophthalmische depot-formulierungen zur periokkularen oder subkonjunktivalen verabreichung | |
| CR9351A (es) | Composiciones y metodos para aplicaicon topica y suministro transdermico de toxina botulinica | |
| TW200616643A (en) | Ophthalmic compositions and methods for treating ophthalmic conditions | |
| WO2006008639A8 (en) | Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody | |
| AR041725A1 (es) | Prevencion, tratamiento de la enfermedad sinucleinopatica y composicion farmacologica | |
| WO2006068877A3 (en) | Sustained-release nanoparticle compositions and methods for using the same | |
| WO2006039704A3 (en) | Pharmaceutical composition and method for treating a joint capsule arthropathy | |
| CL2010001406A1 (es) | Composicion farmaceutica oftalmica que comprende povidona yodada, y un compuesto antiinflamatorio esteroidal, un compuesto antiinflamatorio no esteroidal, un antibacteriano, un antialergico o un compuesto antiglaucoma; y metodo para preservar la composicion. | |
| AR047205A1 (es) | Composiciones oftalmicas que contienen una combinacion sinergica de tres polimeros | |
| WO2006047466A3 (en) | Ophthamological drugs | |
| EP4279063A3 (en) | Ophthalmic pharmaceutical composition, preparation method therefor and application thereof | |
| UY27929A1 (es) | Composiciones farmaceuticas de farmacos semiordenados y polimeros | |
| MX2007004775A (es) | Tratamiento de presbiopia por alteracion del lente. | |
| WO2005020959A3 (en) | Novel drug compositions and dosage forms of topiramate | |
| WO2008027793A3 (en) | Ophthalmic pharmaceutical compositions and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |